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Abstract. 
 
Agrin is a heparan sulfate proteoglycan that 
is required for the formation and maintenance of neu-
romuscular junctions. During development, agrin is se-
creted from motor neurons to trigger the local aggrega-
tion of acetylcholine receptors (AChRs) and other 
proteins in the muscle fiber, which together compose 
the postsynaptic apparatus. After release from the mo-
tor neuron, agrin binds to the developing muscle basal 
lamina and remains associated with the synaptic por-
tion throughout adulthood. We have recently shown 
that full-length chick agrin binds to a basement mem-
brane-like preparation called Matrigel™. The first 130 
 
amino acids from the NH
 
2
 
 terminus are necessary for 
the binding, and they are the reason why, on cultured 
chick myotubes, AChR clusters induced by full-length 
agrin are small. In the current report we show that an 
NH
 
2
 
-terminal fragment of agrin containing these 130 
amino acids is sufficient to bind to Matrigel™ and that 
the binding to this preparation is mediated by laminin-1. 
The fragment also binds to laminin-2 and -4, the pre-
dominant laminin isoforms of the muscle fiber basal 
lamina. On cultured myotubes, it colocalizes with lami-
nin and is enriched in AChR aggregates. In addition, 
we show that the effect of full-length agrin on the size 
of AChR clusters is reversed in the presence of the 
NH
 
2
 
-terminal agrin fragment. These data strongly sug-
gest that binding of agrin to laminin provides the basis 
of its localization to synaptic basal lamina and other 
basement membranes.
 
E
 
fficient
 
 synaptic transmission requires a high local
specialization of pre- and postsynaptic cells. At the
 
neuromuscular junction (NMJ),
 
1
 
 these specializa-
tions include aggregates of acetylcholine receptors (AChRs)
and acetylcholinesterase (AChE) in the muscle cell mem-
brane and accumulated vesicles containing the neurotrans-
mitter acetylcholine in the nerve terminal (for review see
Hall and Sanes, 1993). Differentiation of both pre- and
postsynaptic cells is directed by molecules that are local-
ized to the synaptic portion of the muscle cell basal lamina
(Sanes et al., 1978; Burden et al., 1979). The capability of
the synaptic basal lamina to control and maintain synaptic
differentiation makes it distinct from the extrasynaptic
basal lamina.
Collagen type IV and laminin are the major components
of cell basement membranes. Both molecules assemble
from three separate chains. Individual chains are encoded
by a family of homologous genes giving rise to collagen
type IV and laminin isoforms that differ in their chain
composition (Timpl, 1996). The collagen type IV mole-
cules and the laminins are thought to form independent
networks by self assembly that are linked by entactin/ni-
dogen (Yurchenco and O’Rear, 1994). This scaffold builds
the framework with which several other proteins like per-
lecan, fibulin-1, and fibulin-2 associate (for review see
Timpl and Brown, 1996). While perlecan and nidogen are
found both at synaptic and extrasynaptic sites of the mus-
cle basal lamina, specific isoforms of collagen type IV and
laminin are localized to the NMJ (Sanes, 1995). Other
molecules that are concentrated at the NMJ include the
neuregulins, AChE, and agrin, some of which have been
shown to regulate different aspects of synapse formation
(for review see Ruegg, 1996).
Among the best characterized molecules associated with
synaptic basal lamina is agrin, a heparan sulfate proteogly-
can (HSPG) with an apparent molecular mass on SDS-
PAGE of 400–600 kD (Denzer et al., 1995; Tsen et al.,
1995
 
a
 
). When added to cultured muscle cells, agrin in-
duces the aggregation of AChRs and several other pro-
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Abbreviations used in this paper
 
: AChE, acetylcholinesterase; AChR,
acetylcholine receptor; ECM, extracellular marix; HS-GAG, heparan sul-
fate glycosaminoglycan; HSPG, heparan sulfate proteoglycan; NMJ, neu-
romuscular junction; NtA, NH
 
2
 
-terminal domain in agrin; VF, vitreous
fluid.
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teins that are also enriched at the NMJ in vivo (Nitkin et al.,
1987). Several lines of evidence have led to the hypothesis
that agrin is released from the nerve terminal of motor ax-
ons and causes the local accumulation of AChRs and
other postsynaptic proteins in muscle fibers (McMahan,
1990). Consistent with this hypothesis, agrin-deficient mu-
tant mice lack AChR clusters, and no functional NMJs are
formed (Gautam et al., 1996). In chick agrin, three sites of
alternative splicing have been described. One site is lo-
cated near the NH
 
2
 
 terminus (Denzer et al., 1995; Tsen et al.,
1995
 
b
 
), and two sites, called A and B (y and z in rodents),
are located in the COOH-terminal half of the protein.
Splicing at site B strongly influences agrin’s AChR-aggre-
gating activity. Agrin isoforms with amino acid inserts at
the B-site are highly active in inducing myotubes to aggre-
gate AChRs, while agrin isoforms lacking inserts at this
site are only marginally or not at all active (Ruegg et al.,
1992; Ferns et al., 1993; Gesemann et al., 1995). Tran-
scripts encoding the individual splice variants are differen-
tially distributed. While AChR-aggregating isoforms are
selectively expressed by neuronal cells, isoforms lacking
inserts at site B are predominantly expressed by nonneu-
ronal cells (for review see McMahan et al., 1992; Bowe and
Fallon, 1995).
The local immobilization of motor neuron–derived agrin
in the developing muscle basal lamina is thought to be im-
portant to maintain postsynaptic structures throughout
adulthood (McMahan, 1990). This becomes evident as
AChR-aggregating activity and agrin-like immunoreactiv-
ity remain localized to synaptic basal lamina for several
weeks after degeneration of the cells at the NMJ (Burden
et al., 1979; Reist et al., 1987). In addition to the NMJ,
agrin-like immunoreactivity is also detected in basement
membranes of other nonneuronal tissues, such as blood
capillaries, kidney, and lung (Reist et al., 1987; Godfrey et al.,
1988
 
a
 
; Magill-Solc and McMahan, 1988; Rupp et al., 1991).
Hence, agrin must strongly bind to components of synaptic
basal lamina and other basement membranes.
In a first attempt to characterize the binding of agrin to
extracellular matrix (ECM), we have recently shown that
full-length chick agrin binds selectively to Matrigel™ (Klein-
man et al., 1982), a solubilized basement membrane ex-
tracted from the Engelbreth-Holm-Swarm mouse sarcoma.
This binding required a 130–amino acid–long region at the
NH
 
2
 
-terminal end of agrin (Denzer et al., 1995). AChR
clusters on cultured myotubes were also affected by this
region as clusters induced by full-length agrin were more
numerous but considerably smaller than those induced
by any fragment of agrin without this NH
 
2
 
-terminal region
(Denzer et al., 1995). We now show that a fragment com-
prising this region of agrin is sufficient to bind to Matri-
gel™ and that the binding to this basement membrane
preparation is mediated by laminin-1. The fragment also
binds to laminin-2 and -4, the laminin isoforms expressed
by muscle fibers, and it is concentrated in AChR clusters
on cultured chick myotubes. Moreover, an excess of this
fragment is sufficient to reverse the effect of full-length
chick agrin on the size of AChR clusters. Searches on da-
tabases revealed that the NH
 
2
 
-terminal region is highly
conserved in mouse and human agrin. Based on these
data, the 130 amino acids from the NH
 
2
 
 terminus of agrin
define a laminin-binding domain.
 
Materials and Methods
 
Cell Culture, Transfection, Protein Labeling, 
Immunoprecipitation, and Immunoblot
 
Culturing of primary chick myotubes and transfections of COS-7 (Gluz-
man, 1981) or HEK 293 cells (Graham et al., 1977) were carried out as
described by Gesemann et al. (1995). Iodination of purified protein was
performed as described (Gesemann et al., 1996). 
 
35
 
S labeling, immunopre-
cipitation, and immunoblots were essentially done as described (Denzer
et al., 1995). Recombinant cAgrin
 
7
 
 and c
 
D
 
N15Agrin (see Fig. 1 
 
a
 
) in the
supernatant of transiently transfected COS cells were immunoprecipi-
tated with the antiserum raised against c
 
D
 
N15Agrin (Denzer et al., 1995),
whereas cN25
 
7
 
Fc and r21Fc (see Fig. 1 
 
a
 
) were directly bound to protein
A–Sepharose (Pharmacia, LKB Biotechnology Inc., Piscataway, NJ). 
 
35
 
S-
labeled proteins were analyzed by SDS-PAGE on a 3–12% gradient gel
followed by fluorography. For immunoblots, 3 
 
m
 
g of purified cAgrin
 
7
 
 or
agrin purified from vitreous fluid (VF agrin) and 5 
 
m
 
g of total chick heart
laminins (Brandenberger and Chiquet, 1995) was separated by SDS-
PAGE on a 3–12% gradient gel, transferred to nitrocellulose membrane,
and analyzed as described in Denzer et al. (1995).
 
Expression Constructs
 
cDNA constructs pcAgrin and pc
 
D
 
N15Agrin have been described previ-
ously (Denzer et al., 1995). The sequence encoding parts of the constant
region of mouse immunoglobulin gamma heavy chain (Fc) were obtained
by PCR using the primers sFc
 
—
 
XhoI
 
—
 
BamHI (GGCAGCTCGAG-
GATCCTCGTGCCCAGGGATTGTGGTTG) and asFc
 
—
 
XbaI (GGC-
CCTCTAGATCATTTACCAGGAGAGTGGG). As template, the Fc part
of mouse immunoglobulin (Bowen et al., 1996) was used. Amplification
introduced an XhoI and a BamHI site at the 5
 
9
 
 end and a XbaI site at the
3
 
9
 
 end. The PCR product was digested with XhoI and XbaI and ligated into
the expression vector pcDNAI (InVitrogen, San Diego, CA) to yield pFc. To
generate pcN25
 
7
 
Fc, a second PCR was performed using EcoRI
 
—
 
s-289
(GCATAGAATTCGGCTGCGGGCGATGGG) and as469
 
—
 
BamHI
(CACGAGGATCCCCTCTGCACAGGGGTCCTTG) as primers and
pcAgrin
 
7A4B8
 
 (Denzer et al., 1995) as template. The product coded for the
NH
 
2
 
-terminal domain of chick agrin and contained an EcoRI site at the 5
 
9
 
end and a BamHI site at the 3
 
9
 
 end. The BamHI site enabled the subse-
quent in-frame fusion of this PCR fragment to the Fc sequences by diges-
tion with EcoRI and BamHI and ligation into pFc. pr21Fc was similarly
constructed. The cDNA part encoding ray agrin was isolated by PCR using
the primers EcoRI
 
—
 
s3426 (AGCTTGAATTCAGCCAGTGGAAGTGA-
ATC) and as3967
 
—
 
BamHI (CACGAGGATCCCTTTCTTGGCTGGAC-
AGTG), and r100
 
A4B8
 
 (Gesemann et al., 1995) as template. After digestion
of the PCR product with EcoRI and BamHI, it was ligated into pFc. The se-
quence of pcN25
 
7
 
Fc and r21Fc was verified by DNA sequencing.
 
Antiserum against 
 
b
 
 and 
 
g 
 
Chains of Chick Laminins
 
Antiserum 648 against the 
 
b
 
/
 
g
 
 chains of chick laminin-2 and -4 was gener-
ated as follows. 1 mg of chick heart laminin-2 and -4, purified as described
(Brandenberger and Chiquet, 1995), was loaded on a preparative 3–15%
gradient SDS-PAGE, run under reducing conditions, and blotted onto ni-
trocellulose (BA-85; Schleicher & Schuell Inc., Keene, NH). The protein
band of 200 kD, containing the 
 
b
 
 and the 
 
g
 
 chains, was cut out, suspended
in 0.2 ml PBS, and sonicated on ice until homogenization. The sample was
mixed with 0.2 ml Freund’s complete adjuvant (GIBCO BRL, Gaithers-
burg, MD) and injected intracutaneously into one rabbit. The rabbit was
boosted 1 mo later with the same preparation, suspended in incomplete
Freund’s adjuvant. Antiserum 648 was obtained 14 d later. In immunoblots,
the antiserum recognized the 200-kD band of laminin isoforms from chick
heart, chick gizzard, and mouse laminin-1 (Brandenberger and Chiquet,
1995; Perris et al., 1996). As the only chain common to all these laminins is
the 
 
g
 
1 chain, antiserum 648 must recognize at least this subunit. As the im-
munogen also contained the 
 
b
 
 chain, the antiserum is likely to recognize
this subunit as well.
 
Protein Purification
 
Recombinant cAgrin
 
7
 
 was obtained from stably transfected HEK 293 cells,
whereas VF agrin was derived from eyes of day 14 chick embryos (Ruegg
et al., 1989). 100 ml of serum-free conditioned medium or 50 ml of vitre-
ous fluid was passed over a Mono Q–Sepharose (Pharmacia Diagnostics 
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AB, Uppsala, Sweden). The column was washed with 20 mM Tris-HCl,
pH 7.2, 500 mM NaCl, and bound proteins were eluted with a linear gradi-
ent of NaCl from 500 mM to 2 M. Individual fractions with agrin immu-
noreactivity, as determined by an ELISA (Gesemann et al., 1995), were
analyzed on SDS-PAGE (3–12% gradient) and visualized by silver stain-
ing (Morrissey, 1981). Agrin-containing fractions were pooled and dia-
lyzed three times against PBS. Agrin concentration of such a preparation
was determined by ELISA. cN25
 
7
 
Fc and r21Fc from transiently trans-
fected COS-7 cells were purified with protein A–Sepharose (Pharmacia)
according to the manufacturer’s advice. Purity of recovered protein was
checked by SDS-PAGE and silver staining. The protein concentration
was determined as described (Lowry et al., 1951), using the DC Protein
assay kit (BioRad Labs, Hercules, CA) and BSA as a standard. Mouse
laminin-1, purified from mouse Engelbreth-Holm-Swarm sarcoma as de-
scribed (Timpl et al., 1979), was provided by Th. Schulthess (Biozentrum,
University of Basel, Basel, Switzerland). Mouse nidogen, isolated from
conditioned medium of stably transfected HEK 293 cells (Fox et al., 1991),
and mouse perlecan (Timpl et al., 1979) were provided by Dr. R. Timpl
(Max Planck Institute, Munich, Germany). Human collagen type IV (Weber
et al., 1984; Ries et al., 1995) was obtained from Dr. K. Kühn (Max Planck
Institute) and chick 
 
a
 
-dystroglycan, isolated from skeletal muscle (Bran-
caccio et al., 1995), was a gift of Dr. A. Brancaccio (Biozentrum, Univer-
sity of Basel). Chick laminin isoforms (laminin-2 and -4) were purified
from chick heart as described by Brandenberger and Chiquet (1995). Only
laminin preparations functional in a neurite outgrowth assay (Branden-
berger and Chiquet, 1995) were used for agrin-binding studies.
 
Solid-Phase Radioligand Binding Assay
 
Proteins were diluted to 10 
 
m
 
g/ml with 50 mM sodium bicarbonate, pH 9.6
(coating buffer), and immobilized on 96-well plates (Becton-Dickinson,
Bedford, MA) by incubation overnight at 4
 
8
 
C. Remaining binding sites
were blocked for 1 h with TBS containing 3% BSA, 1.25 mM CaCl
 
2
 
, and
1 mM MgCl
 
2
 
 (blocking solution). 
 
125
 
I-cAgrin
 
7
 
 or 
 
125
 
I-cN25
 
7
 
Fc, diluted in
blocking solution, was added and incubated for 3 h. After washing with
TBS, 1.25 mM CaCl
 
2
 
, 1 mM MgCl
 
2
 
 four times, bound radioactivity in each
well was counted with a gamma counter. Solubilization with SDS sample
buffer and subsequent analysis on SDS-PAGE followed by silver staining
confirmed that the proteins were indeed coated onto the plastic surface.
Alternatively, mAb 5B1 diluted to 10 
 
m
 
g/ml in coating buffer was first
immobilized by overnight incubation at 4
 
8
 
C. Remaining binding sites were
saturated with blocking solution for 1 h. Then 3 
 
m
 
g/ml agrin was added.
After 1 h of incubation, the plates were washed three times with blocking
solution and processed with 
 
125
 
I–laminin-1 as described above.
To calculate half-maximal binding (EC
 
50
 
) of cAgrin
 
7
 
 to laminin-1, indi-
vidual data points of the dose-response were fit by the following equation:
 
Y
 
 
 
5
 
 (
 
X
 
/EC
 
50
 
)/(1
 
1
 
X
 
/EC
 
50
 
) 
 
3
 
 
 
P1.
 
 This equation assumes a single class of
equivalent and independent binding sites, where 
 
Y
 
 represents cpm, 
 
X
 
 rep-
resents the concentration of agrin, and 
 
P1
 
 represents cpm at saturation.
 
Immunocytochemistry
 
Double staining of agrin in COS-7 cells: COS cells, transiently transfected
with cDNAs encoding cAgrin
 
7
 
 and c
 
D
 
N15Agrin, were grown on Matri-
gel™ (Becton-Dickinson) and stained for agrin as described elsewhere
(Denzer et al., 1995). Cells transfected with cDNAs encoding cN25
 
7
 
Fc and
r21Fc were also stained as described in Denzer et al. (1995), except that
fluorescein-conjugated goat anti–mouse IgG (1:200; Cappel, Organon Tek-
nika Corp., West Chester, PA) was used for the extracellular staining and
that, before permeabilization and staining with rhodamine-conjugated goat
anti–mouse IgG (1:200; Cappel), residual binding sites were blocked with
unlabeled goat anti–mouse IgG (1:50; Cappel).
Primary chick myotubes were incubated with 200 nM c21
 
B8
 
 (Gesemann
et al., 1995) for 16 h at 37
 
8
 
C. To localize cN25
 
7
 
Fc, 20 nM of this fragment
was included. Cultures were rinsed with culture medium, and to visualize
individual components, they were stained with the following reagents:
AChRs with 4 
 
3
 
 10
 
2
 
8
 
 M rhodamine–
 
a
 
-bungarotoxin (Molecular Probes,
Eugene, OR); cN25
 
7
 
Fc with 5 
 
m
 
g/ml biotinylated goat anti–mouse IgG (Mo-
lecular Probes) followed by 3 
 
m
 
g/ml fluorescein-conjugated streptavidin
(Jackson ImmunoResearch Laboratories, Inc., West Grove, PA); 
 
b
 
/
 
g
 
 sub-
units of laminin with antiserum 648 (1:1,000) followed by Cy3™-conju-
gated goat anti–rabbit IgG (1:200; Jackson ImmunoResearch Laborato-
ries, Inc.); and 
 
b
 
2 chain of laminin with mAb C4 (10 
 
m
 
g/ml) followed by
5 
 
m
 
g/ml biotinylated goat anti–mouse IgG and 3 
 
m
 
g/ml fluorescein-conju-
gated streptavidin. The first incubation was done for 1 h at 37
 
8
 
C. Cultures
were then washed with culture medium and fixed for 30 min at room tem-
 
perature with 4% paraformaldehyde, 11% sucrose in 0.1 M potassium
phosphate, pH 7.2. After rinsing the cells with PBS and PBS 
 
1
 
 20 mM gly-
cine, the cultures were incubated for 1 h with the secondary reagents indi-
cated before, diluted in PBS 
 
1
 
 2% normal goat serum (PBSN). After rins-
ing the cells with PBS, cultures were either dehydrated with 95% ethanol
at 
 
2
 
20
 
8
 
C or incubated once more with the tertiary reagent diluted in
PBSN. Coverslips were mounted with Vectashield™ (Vector Laborato-
ries, Inc., Burlingame, CA), and cultures were examined with a micro-
scope equipped for epifluorescence (Leica Inc., Deerfield, IL).
 
Competition Experiment and AChR Aggregation
 
Chick muscle cells were preincubated with 500 nM of cN25
 
7
 
Fc for 4 h at
37
 
8
 
C. Conditioned medium from transiently transfected COS cells con-
taining 100 pM cAgrin
 
7A4B8
 
 or c
 
D
 
N15Agrin
 
A4B8
 
 was added for 12 h at
37
 
8
 
C. AChRs were visualized and analyzed as described in Gesemann et al.
(1995). Since cAgrin
 
7A4B8
 
-induced AChR clusters were very small, aggre-
gates with the longer axis of 
 
>
 
1 
 
m
 
m were included.
 
Results
 
The NH
 
2
 
-terminal End of Agrin Is Sufficient to Bind
to ECM
 
We have recently shown that recombinant full-length
chick agrin (cAgrin; Fig. 1 
 
a
 
) binds to a solubilized mixture
of ECM molecules, called Matrigel™. In contrast to full-
length agrin, a fragment that lacks the first 130 amino acids
from the NH
 
2
 
 terminus (c
 
D
 
N15Agrin; Fig. 1 
 
a
 
) did not
bind to this ECM preparation (Denzer et al., 1995). In this
130–amino acid–long stretch, a site of alternative mRNA
splicing is found (Denzer et al., 1995; Tsen et al., 1995
 
b
 
).
Both splice variants are capable of binding to Matrigel™,
although with different binding strengths (Denzer et al.,
1995). In the current report we have investigated the bind-
ing of the splice variant that includes the seven–amino
acid–long insert (Fig. 1 
 
a
 
). This splice variant is selectively
expressed by embryonic chick motor neurons (Denzer et
al., 1995) and is also highly expressed in embryonic chick
brain (Tsen et al., 1995
 
b).
To see whether the NH2-terminal region of agrin alone
is sufficient to bind to Matrigel™, we engineered a cDNA
construct that encodes an agrin fragment comprising the
NH2-terminal region and the first follistatin-like domain.
To facilitate detection and purification of the fragment, it
was fused to the constant region of a mouse IgG (Fc; Bowen
et al., 1996), giving rise to the fragment termed cN257Fc
(Fig. 1 a). A chimeric construct of the most COOH-termi-
nal, 21-kD fragment of agrin from the marine ray (Smith
et al., 1992) and the Fc part (r21Fc; Fig. 1 a) was used as
a control. All recombinant proteins were efficiently syn-
thesized and secreted from COS cells as shown by precipi-
tation of 35S-labeled proteins from conditioned medium of
transiently transfected cells (Fig. 1 b). The high apparent mo-
lecular mass of 400–600 kD of cAgrin7 and cDN15Agrin on
SDS-PAGE is a result of heparan sulfate glycosaminogly-
can (HS-GAG) chains that are attached to the 225-kD core
protein (Denzer et al., 1995). The chimeric constructs,
cN257Fc and r21Fc, were also secreted from the trans-
fected cells, and they displayed the expected molecular
mass of z69–65 and 61 kD, respectively (Fig. 1 b). SDS-
PAGE of the chimeric proteins under nonreducing condi-
tions demonstrated that the intermolecular disulfide bonds
of the Fc region dimerize the fragments (data not shown).
The binding to Matrigel™ was assayed using transientlyThe Journal of Cell Biology, Volume 137, 1997 674
transfected COS cells that were grown on tissue culture
dishes coated with this basement membrane preparation.
As previously shown (Denzer et al., 1995), cAgrin7 was de-
posited on Matrigel™ (Fig. 2, a and a9), and no extracellu-
lar agrin-like immunoreactivity was observed with COS
cells expressing cDN15Agrin (Fig. 2, b and b9). Extracellu-
lar deposits of the recombinant proteins, cN257Fc and
r21Fc, were visualized with fluorescein-conjugated goat
anti–mouse IgG antibodies added to nonfixed, nonperme-
abilized cells. The cells were subsequently permeabilized
and stained with rhodamine-conjugated goat anti–mouse
IgG antibodies to identify transfected cells. As shown in
Fig. 2, c and c9, cN257Fc was deposited on Matrigel™
around the transfected COS cells, which demonstrates that
the NH2-terminal region is sufficient to bind to this ECM
mixture. The binding is not caused by the Fc part, as no
deposits were seen with r21Fc-transfected cells (Fig. 2, d
and d9).
Laminin-1 Is a Binding Partner for Agrin
Matrigel™ consists of a mixture of several ECM mole-
cules, such as collagen type IV, laminin-1, nidogen/entactin,
and perlecan (Kleinman et al., 1982). To identify the com-
ponents to which agrin binds, a solid-phase radioligand
binding assay was used (Gesemann et al., 1996). Laminin-1
and perlecan were purified from the Engelbreth-Holm-
Swarm mouse tumor (Timpl et al., 1979), and collagen
type IV was isolated from human placenta (Weber et al.,
1984; Ries et al., 1995). After coating the purified proteins
onto the plastic surface of a microtiter plate, wells were in-
cubated with 5 nM 125I-cAgrin7 or 125I-cN257Fc and bound
radioactivity was measured. Both agrin constructs bound
to laminin-1 (Fig. 3), while no or only little binding was
seen to perlecan and collagen type IV (data not shown).
Since laminins bind to nidogen with high affinity (Kd z1
nM; Fox et al., 1991), most laminin preparations also con-
tain nidogen (Paulsson et al., 1987). To test whether the
binding of agrin to laminin-1 was due to nidogen, we also
measured binding of cAgrin7 and cN257Fc to recombinant
mouse nidogen, expressed in stably transfected HEK 293
cells (Fox et al., 1991). No binding was observed for both
agrin constructs (Fig. 3). Hence, the binding of agrin to the
laminin–nidogen complex is based on a direct interaction
with laminin-1. As expected from previous experiments
(Bowe et al., 1994; Campanelli et al., 1994; Gee et al., 1994;
Sugiyama et al., 1994; Gesemann et al., 1996), cAgrin7 also
bound to a-dystroglycan, purified from chick skeletal mus-
cle (Brancaccio et al., 1995; Fig. 3 a). In contrast, the NH2-
terminal fragment, cN257Fc, did not bind (Fig. 3 b). This is
consistent with the notion that the binding site to this pe-
ripheral membrane protein resides in its COOH-terminal
Figure 1. Structure and biochemical analysis of agrin constructs. (a) Structural organization of chick agrin and of fragments used in this
study. Symbols and designations of individual domains are according to Bork and Bairoch (1995. Trends Biochem. Sci. 20): FS, follista-
tin-like module; EG, EGF-like module; LE, laminin EGF-like module; SEA, module first found in sea urchin sperm protein, enterokinase
and agrin; LamG, laminin G–like module. Furthermore, the fragment of the constant region of mouse immunoglobulin gamma heavy
chain (Fc), the chick agrin signal sequence (SS), the hemagglutinin signal sequence (SH), the serine/threonine rich regions (S/T), poten-
tial N-linked glycosylation sites, conserved GAG side chain attachment sites, and the sites of alternative mRNA splicing are indicated.
The NH2-terminal region of agrin characterized in this study is named NtA domain. Notes: (1) Inserts at splice sites A and B are not
specified. They are mentioned in the text if relevant for the experiment; and (2) the construct cDN15Agrin was previously called cFull
(Denzer et al., 1995; Gesemann et al., 1995) and covers the coding region of chick agrin as described by Tsim et al. (1992). (b) Autora-
diogram of the 35S-labeled agrin fragments depicted in a after precipitation from conditioned medium of transiently transfected COS
cells. cAgrin7 and cDN15Agrin were immunoprecipitated with anti-cDN15Agrin antibodies (Denzer et al., 1995). cN257Fc and r21Fc were
precipitated with protein A–Sepharose. Proteins were separated by 3–12% SDS-PAGE. The two protein bands of cN257Fc are probably
due to inefficient stop of protein translation at the COOH-terminal end of the construct. Molecular masses in kD of standard proteins
are indicated.Denzer et al. Agrin Binds to Laminins 675
half of agrin (Bowe et al., 1994; Campanelli et al., 1994;
Gee et al., 1994; Sugiyama et al., 1994; Gesemann et al.,
1996). Accordingly, only the laminin-binding site is com-
mon to cN257Fc and cAgrin7. In addition, no binding of
125I-r21Fc was observed to any of the components tested
(data not shown), which excludes a contribution of the Fc
part in the binding of cN257Fc to laminin-1.
The strength of the binding of agrin to laminin-1 was
measured by dose-response curves using 125I-cAgrin7. On
immobilized laminin-1, half-maximal binding (EC50) was
Figure 2. The NH2-terminal end of agrin is sufficient to bind to Matrigel™. COS-7 cells, which had been transiently transfected with
cDNAs encoding the agrin constructs indicated on the left of each row, were grown on Matrigel™. Deposition of recombinant protein
onto Matrigel™ (right column) was monitored by staining living cells with the appropriate antibodies. To identify agrin-expressing cells,
antibodies were added after permeabilizing the cells (left). To detect cAgrin7 and cDN15Agrin deposits, antiagrin antiserum followed by
a fluorescein-conjugated secondary antibody was used (a9 and b9). cN257Fc and r21Fc deposits were visualized with a fluorescein-conju-
gated goat anti–mouse IgG (c9 and d9). Permeabilized cells were incubated with antiagrin mAb 5B1 followed by a rhodamine-conju-
gated secondary antibody (a and b) or with rhodamine-conjugated goat anti–mouse antibody (c and d). Only cells synthesizing cAgrin7
and cN257Fc show extracellular deposits of recombinant protein (a9 and c9). Bar, 40 mm.The Journal of Cell Biology, Volume 137, 1997 676
reached at z5 nM (Fig. 4), suggesting a rather strong in-
teraction of agrin with laminin-1. This binding is of similar
strength as the binding of laminin-1 to nidogen (Kd z1 nM;
Fox et al., 1991). At 4 nM 125I-cAgrin7, 90.3 6 0.5% (mean 6
SEM; n 5 3) of the binding was competed with 100 nM un-
labeled cN257Fc, indicating that the majority of the bind-
ing of full-length agrin to laminin-1 is mediated by the
NH2-terminal end. Since agrin is an HSPG (Denzer et al.,
1995; Tsen et al., 1995a) and laminin-1 is known to bind to
heparin (Ott et al., 1982; Yurchenco et al., 1993), the resid-
ual binding of cAgrin7 to laminin-1 could be due to the
binding of the HS-GAG side chains of agrin to the hep-
arin-binding site of laminin-1. Indeed, only the HS-GAG
side chain-carrying construct cAgrin7, but not cN257Fc,
binds to the elastase fragment E3, which contains the ma-
jor heparin-binding site of laminin-1 (Ott et al., 1982; data
not shown). In summary, our data show that laminin-1, the
laminin isoform present in Matrigel™, is a basement mem-
brane binding partner for agrin. Furthermore, they show
that the interaction is mediated by the NH2-terminal end
of agrin, and we therefore propose that this part of agrin
forms a structural unit (see also Discussion).
Agrin Expressed in Developing Chick Retina Binds
to Laminin-1
The results presented so far show that recombinant chick
agrin, expressed in mammalian cells, binds to laminin-1. If
this binding were important for agrin’s function in vivo,
agrin purified from tissue should have the same binding
properties. To test this, agrin was isolated by anion ex-
change chromatography from the vitreous fluid of embry-
onic day 14 chick eyes, a rich source for agrin and other
molecules secreted from retinal cells (e.g., Ruegg et al., 1989;
Halfter, 1993; Denzer et al., 1995). As a control, cAgrin7
from conditioned medium of stably transfected HEK 293
cells was purified by the same procedure. When agrin-con-
taining fractions were assayed by Western blot, agrin-like
protein from vitreous fluid and cAgrin7 had a high appar-
ent molecular mass (Fig. 5 a, left), which is consistent with
previous results (Denzer et al., 1995). The bands with an
apparent molecular mass of z115 kD are probably due to
proteolytic degradation similar to what has been reported
elsewhere (e.g., Nitkin et al., 1987; Godfrey, 1991; Rupp
et al., 1991; Denzer et al., 1995). The same samples were
also probed with antiserum 245, raised against native chick
heart laminin (Brubacher et al., 1991). No laminin-like im-
munoreactivity was observed in the samples containing
cAgrin7, derived from stably transfected HEK 293 cells,
whereas immunoreactive bands were visible in the sample
containing agrin from the vitreous fluid (Fig. 5 a, right).
The strong immunoreactive band with the apparent mo-
lecular mass of 200 kD most likely corresponds to the b/g
Figure 3. Agrin binds to
laminin-1. Solid-phase radio-
ligand binding assay with
purified proteins. Mouse
laminin-1, nidogen, and chick
a-dystroglycan were immobi-
lized in microtiter plates and
subsequently incubated with
125I-cAgrin7 or 125I-cN257Fc.
Each value represents bind-
ing after subtraction of the
background (BSA-coated
wells). The values given are
the mean 6 SD from one
representative experiment
with three independent mea-
surements in the case of 125I-
cN257Fc and two measure-
ments for 125I-cAgrin7. (a) 5
nM of 125I-cAgrin7 bound to a-dystroglycan and to laminin-1, but not to nidogen. Background counts were 89 6 15 cpm. (b) 5 nM 125I-
cN257Fc bound to laminin-1 but not to a-dystroglycan and nidogen. Background counts were 65 6 3 cpm. These experiments show that
the binding of agrin to laminin is mediated by the NH2-terminal end of agrin. Counts measured in a and b cannot be compared because
cAgrin7 and cN257Fc are iodinated to different extents.
Figure 4. Binding of agrin to laminin-1 is of high affinity. Dose-
response curve of the binding of 125I-cAgrin7 to laminin-1. Half-
maximal binding was reached at z5 nM, suggesting a rather
strong binding of agrin to laminin-1. The binding curve shown re-
sults from one representative experiment. Background values
(BSA-coated wells) are subtracted from each data point. Values
shown are the mean 6 SEM from three measurements.Denzer et al. Agrin Binds to Laminins 677
subunits of laminin isoforms, while the faint bands with
the molecular masses of 400 and 150 kD could represent a
subunits and nidogen, respectively (Brubacher et al., 1991).
The copurification of chick laminin isoforms from the vit-
reous fluid with agrin by a procedure that is selective for
highly charged anions is unexpected and may reflect the
binding of laminin to agrin. Consistent with this idea,
Halfter (1993) reported copurification of laminin with a
chick HSPG, which later was shown to be agrin (Tsen et al.,
1995a).
To test directly whether VF agrin is capable of binding
to laminin-1, we performed a modified solid-phase radioli-
gand binding assay. In this assay, purified cAgrin7 or VF
agrin was immobilized on microtiter plates that had been
first coated with the antiagrin mAb 5B1 (Reist et al., 1987).
To these wells, 5 nM of 125I–laminin-1 was added and
bound radioactivity was measured. As shown in Fig. 5 b,
125I–laminin-1 bound to cAgrin7 and VF agrin. In both
cases, binding was competed by more than 97% by includ-
ing 100 nM of unlabeled cN257Fc during the incubation
with 125I–laminin-1 (Fig. 5 b). These experiments show
that agrin synthesized and secreted by cells of the chick
retina can bind to laminin-1 and that this binding is also
mediated by the NH2-terminal domain of agrin. Although
the same amount of agrin was added to the 5B1-coated mi-
crotiter wells, the amount of 125I–laminin-1 bound to VF
agrin was only half of that bound to cAgrin7. The most
likely explanation for this difference is that some of the
binding sites in VF agrin may already be occupied by lami-
nin isoforms from the vitreous fluid that copurified with
VF agrin (see Fig. 5 a). In summary, chick agrin synthe-
sized in vivo has the same laminin-binding properties as
recombinant agrin, and its binding is also mediated by the
NH2-terminal domain.
The Laminin-binding Domain Is Highly Conserved in 
Mouse and Human Agrin
The NH2-terminal region required for the binding of agrin
to laminin-1 has so far only been described in chick (Den-
zer et al., 1995). Full-length cDNA encoding rat agrin lacks
this region and instead, the first follistatin-like domain is
preceded by a sequence that has been proposed to serve as
signal sequence (Rupp et al., 1991). To see whether the
NH2-terminal region of chick agrin is found in other spe-
cies, we searched for homologous sequences using the
BLAST algorithm (Altschul et al., 1990). Four expressed
sequence tags, isolated from different tissues in mouse and
in human (Lennon et al., 1996), closely matched this amino
acid sequence. Sequencing of the clones confirmed that
the deduced amino acid sequences of mouse and human
agrin are highly homologous to each other and to chick
agrin (Fig. 6). The homology starts at residue 26 of chick
agrin, which corresponds to the predicted cleavage site for
the signal sequence (Denzer et al., 1995). In the stretch
from residue 26 to 149, 96% of the amino acids are identi-
cal between mouse and human, and 90% are identical be-
tween chick and the mammalian sequences (Fig. 6). This is
by far the most highly conserved region in agrin (see also
Tsim et al., 1992), suggesting that this domain may also
confer binding to laminin in mammals.
Agrin Binds to Laminin Isoforms Expressed at the NMJ
The data presented so far show that agrin binds to mouse
laminin-1. The laminins are a family of heterotrimeric gly-
coproteins composed of a, b, and g chains (Burgeson et al.,
1994; Timpl, 1996). Each laminin is characterized by its
chain composition, for example laminin-1 is a trimer with
the a1, the b1, and the g1 chains. Recent data suggest that
Figure 5. Chick agrin synthesized in vivo
contains the laminin-binding domain. (a)
Western blot of recombinant cAgrin7 and
agrin purified from vitreous fluid (VF agrin).
Transferred protein were stained with anti-
agrin antibodies (a agrin) or antilaminin an-
tibodies (a laminin). Agrin purified from vit-
reous fluid has approximately the same
apparent molecular mass as recombinant
full-length agrin. The band detected at z115
kD most likely results from proteolytic deg-
radation. No laminin-like immunoreactivity
is associated with recombinant agrin (right).
In contrast to this, the agrin-containing frac-
tions from vitreous fluid are positive for
laminin-like protein. Based on their appar-
ent molecular mass and the specificity of the
antiserum used (Brubacher et al., 1991),
they may represent nidogen (z150 kD), the
b and g chain (200 kD), and a chain (400
kD). Molecular masses of standard proteins
are given in kD. (b) cAgrin7 and agrin from
vitreous fluid were bound to immobilized
antiagrin mAb 5B1 and incubated with 125I–
laminin-1. The data result from one repre-
sentative experiment and are the mean 6 SD of three measurements. Background counts (no agrin added; 132 6 15 cpm) was sub-
tracted. 100 nM cN257Fc (1 cN257Fc) inhibits binding of 125I–laminin-1 to cAgrin7 and VF agrin by more than 97%, indicating that the
NH2-terminal domain is responsible for the binding.The Journal of Cell Biology, Volume 137, 1997 678
laminin-1 is not expressed in muscle basal lamina but in-
stead is replaced by laminin-2 and -4 (Schuler and Sorokin,
1995). Laminin-2 (a2, b1, g1) is present early in develop-
ment throughout the extracellular matrix of muscle fibers.
In adult muscle, it is expressed in the extrasynaptic region
of the basal lamina. Laminin-4 (also called s-laminin; Hunter
et al., 1989), in which the b1 chain is replaced by the b2
chain, is expressed later in development and localizes to
the synaptic portion of the muscle cell basal lamina (Sanes
et al., 1990).
Since we were interested in whether agrin’s NH2-termi-
nal domain would also mediate the tethering to muscle cell
basal lamina, we measured binding of cAgrin7 and cN257Fc
to laminin-2 and -4. The source for laminin-2 and -4 was a
laminin preparation isolated from adult chick heart after
EDTA extraction and sequential purification by wheat
germ agglutinin Sepharose and immunoaffinity chroma-
tography (Brandenberger and Chiquet, 1995). As shown
by Western blot analysis using antiagrin antibodies, this
laminin preparation contained substantial amounts of agrin-
like protein (Fig. 7 a). As this laminin preparation did not
acid sequences of mouse and human agrin that precede the pro-
posed signal peptide cleavage site (*) are not homologous to
chick and consist mainly of hydrophobic amino acids. Thus, as in
chick these stretches might be part of a signal sequence (lower-
case letters). The homology between chick and rat begins at Asp
157 immediately after the boundary where chick is alternatively
spliced. The human and mouse sequences lack the seven–amino
acid–long insert at this splice site (dashes). These sequence data
are available from GenBank/EMBL/DDBJ under accession num-
ber U84406 (human agrin) and U84407 (mouse agrin).
Figure 6. The laminin-binding domain is present in mouse and
human agrin. Deduced amino acid sequences of the expressed se-
quence tags (Lennon et al., 1996) from mouse and human agrin
were aligned to the first 173 amino acids of chick agrin. In addi-
tion, the first 67 amino acids of rat agrin are shown. Amino acids
identical to chick agrin are denoted with dots. The small letters in
the chick sequence represent the proposed signal sequence (Den-
zer et al., 1995) with the initiator methionine (bold) and the pro-
posed signal sequence cleavage site (*). Underlined amino acids
show the position of the tryptic peptide derived from a HSPG of
bovine kidney (Hagen et al., 1993). Homology between chick and
human starts after the signal sequence cleavage site of chick (Cys
26). Amino acids between Cys 26 and Glu 149 are almost 90%
identical between human, mouse, and chick. Note that the amino
Figure 7. Agrin binds to
laminin isoforms expressed
in muscle. (a) Immunoblot
using antiagrin antibodies of
laminin isoforms purified
from EDTA extracts of adult
chick heart by immunoaffin-
ity column with the anti-g1
subunit–specific mAb 11B7
(Brandenberger and Chi-
quet, 1995). Agrin-like pro-
tein with the same apparent
molecular mass as cAgrin7 is
detected in the laminin prep-
aration. Since no a-dystro-
glycan was detected in the
same laminin preparation
(data not shown), the copuri-
fication of agrin suggests that
laminins are associated with
agrin in muscle tissue. (b and
c) Agrin binds directly to pu-
rified chick laminin-2 and -4.
Equal amounts of the two
laminins were immobilized on microtiter plates and incubated either with 5 nM of iodinated cAgrin7 (b) or cN257Fc (c). Values given
are the result of one representative experiment and represent the mean 6 SD of three measurements where the background (BSA-
coated wells) has been subtracted. Background values were 163 6 24 cpm in b and 75 6 11 cpm in c. The binding of cAgrin7 to laminin-4 is
fivefold stronger than to laminin-2 (b) and a similar difference in the binding (fourfold) is observed with cN257Fc (c). Note that the dif-
ference in the counts measured with 125I-cAgrin7 and 125I-cN257Fc is due to different iodination efficiencies.Denzer et al. Agrin Binds to Laminins 679
contain a-dystroglycan, detected by a transfer overlay as-
say using iodinated chick agrin (data not shown), we con-
clude that the copurification of agrin with laminin iso-
forms from cardiac muscle is most likely a consequence of
the association of agrin with the laminins. To test directly
whether laminin-2 and -4 are binding proteins for agrin,
we performed a solid-phase radioligand binding assay us-
ing purified laminin isoforms. With the same amount of
laminin-2 and -4 coated on the microtiter wells, 5 nM of
125I-cAgrin7 gave a clear signal on laminin-2 and a fivefold
stronger signal on laminin-4 (Fig. 7 b). Like cAgrin7, the
NH2-terminal fragment, cN257Fc, also bound approxi-
mately four times more strongly to laminin-4 than to lami-
nin-2 (Fig. 7 c). The weaker signal on laminin-2 was not
due to a contamination with laminin-4, since this isoform
represents less than 5% in the laminin-2 preparation
(Brandenberger et al., 1996). A difference in the coating
efficiency between laminin-2 and -4 was also excluded be-
cause equal amounts were immobilized when tested with
an mAb specific for the a2 chain (Brandenberger et al.,
1996). In summary, full-length chick agrin binds to both
laminin-2 and -4, but at this particular concentration the
interaction with the extrasynaptic laminin-2 is of lower ap-
parent affinity.
Many proteins that are highly concentrated at the NMJ
in vivo are also found in AChR clusters in vitro (for review
see Bowe and Fallon, 1995). These include proteins of the
ECM, such as HSPG (Wallace, 1989) and laminin (Nitkin
and Rothschild, 1990). Consequently, the laminin-binding
fragment, cN257Fc, should colocalize with AChR clusters.
To test this, AChR aggregation was induced on cultured
chick myotubes with 200 nM c21B8, the minimal COOH-
terminal agrin fragment required for AChR aggregation
(Gesemann et al., 1995), and 20 nM of cN257Fc was in-
cluded. After 16 h, AChR clusters were visualized with
rhodamine–a-bungarotoxin and myotube-bound cN257Fc
was stained with biotinylated goat anti–mouse IgG fol-
lowed by fluorescein-conjugated streptavidin. As shown in
Fig. 8 (first row), cN257Fc localized to the agrin-induced
AChR clusters. cN257Fc also displayed a more widespread
distribution, often along the edge of the myotubes (Fig. 8,
arrowhead). In myotubes, where AChR aggregation had
been induced with c21B8, but no cN257Fc was included, no
specific staining was seen (Fig. 8, second row). These re-
sults illustrate that binding sites for the NH2-terminal frag-
ment of agrin are concentrated in AChR clusters but are
also found on the remaining surface of the myotube.
To look at the relationship between the localization of
cN257Fc and laminin, antiserum 648, directed against the b
and g chains of laminin-2 and -4, was used. Examination of
many myotubes showed that the distribution of myotube-
bound cN257Fc matched laminin-like immunoreactivity
(Fig. 8, third row). In addition, staining with the mAb
11B7, directed against the g1 chain of chick laminins (Bran-
denberger and Chiquet, 1995), gave the same staining pat-
tern (data not shown). Since these antibodies do not dis-
tinguish between laminin-2 and -4, we also applied mAb
C4, recognizing the b2 chain, to localize the synapse-spe-
cific laminin isoform on myotubes (Hunter et al., 1989). In
Fig. 8 (fourth row), staining with the b2-specific mAb C4 is
shown. As reported for spontaneous AChR clusters on
mouse C2 myotubes (Martin et al., 1995), the b2 chain was
concentrated in AChR clusters on chick myotubes. Inter-
estingly, no or only little laminin b2-like immunoreactivity
was detected outside of the clusters. This differs from the
pattern obtained with mAbs specific for the g1 or the a2
chain of laminin, where immunoreactivity was also seen
along the edge of myotubes (data not shown). In sum-
mary, these experiments demonstrate that the binding
sites for agrin coincide well with the distribution of lami-
nin on cultured myotubes, and they suggest that laminin-4
mediates binding of agrin to AChR clusters.
Binding of Agrin to Laminin Alters the Size of the 
AChR Aggregates
AChR aggregates induced by the active full-length splice
Figure 8. Binding sites for agrin on cultured chick myotubes colo-
calize with AChRs and laminin. Cultured chick myotubes were in-
duced to form AChR clusters with 200 nM c21B8. Simultaneously,
20 nM cN257Fc were included. AChR aggregates were stained by
rhodamine–a-bungarotoxin, and cN257Fc bound to the myotubes
was visualized with biotinylated goat anti–mouse IgG followed by
fluorescein-conjugated streptavidin. cN257Fc is concentrated in
AChR clusters and is distributed along the edges of the myotubes
(arrowhead). No staining is seen in the absence of this fragment
(2cN257Fc). Consistent with the idea that cN257Fc binds to lami-
nin, the distribution of myotube-bound cN257Fc resembles the
staining pattern obtained with anti-b/g-specific antiserum 648 (b/
g). The b2 chain of laminin, also called s-laminin, is concentrated
in AChR clusters. In light of the colocalization of cN257Fc and
AChR clusters, laminin-4 (a2, b2, g1) is a binding partner of
agrin in these clusters. Bar, 40 mm.The Journal of Cell Biology, Volume 137, 1997 680
variant cAgrin7A4B8 are more than twofold smaller than
those induced by the fragment cDN15AgrinA4B8 lacking the
first 130 NH2-terminal amino acids (Denzer et al., 1995).
Aggregation of AChRs induced by agrin is mainly based
on the lateral migration of diffusely distributed molecules
(Godfrey et al., 1984). We have speculated that the bind-
ing of cAgrin7A4B8 to ECM influences this process by im-
mobilizing agrin in the ECM. If this were so, inhibition
of the binding of cAgrin7A4B8 to muscle laminins should
result in AChR clusters with the same size as AChR clus-
ters induced by cDN15AgrinA4B8. Myotubes incubated
with cAgrin7A4B8 had considerably smaller AChR aggre-
gates than those incubated with cDN15AgrinA4B8 (Fig. 9 a).
When available laminin-binding sites for full-length agrin
were blocked by 500 nM cN257Fc, cAgrin7A4B8-induced
AChR clusters became indistinguishable from those in-
duced by cDN15AgrinA4B8 (Fig. 9 a). In contrast to this,
500 nM of cN257Fc did not alter the shape of AChR aggre-
gates induced by cDN15AgrinA4B8. Quantification of this
effect with a computerized image analysis system con-
firmed that the presence of cN257Fc increased the average
size of AChR aggregates induced by cAgrin7A4B8 approxi-
mately twofold, while the average size of cDN15AgrinA4B8-
induced AChR clusters was not affected (Fig. 9 b). These
experiments provide evidence that the smaller size of the
AChR clusters induced by full-length agrin is mainly
based on its binding to laminin isoforms expressed by the
myotubes.
Discussion
Agrin is a large, multidomain protein that is associated
with basement membranes in many tissues (for review see
Denzer et al., 1996). In the current study, we investigated
the molecular basis of agrin’s binding to basement mem-
brane. We found that agrin binds with high affinity to
laminin isoforms, including those that are concentrated at
the NMJ, and we have mapped the main laminin-binding
site to the NH2-terminal end of agrin. Agrin has been shown
to be a key regulator of synaptic differentiation at the NMJ
(McMahan, 1990; Gautam et al., 1996), and thus we will
mainly discuss the significance of the binding of agrin to
laminin in this process.
The Laminin-binding Domain of Agrin
Defines a Novel Module
At the outset of the current work, it was known that the
binding of recombinant chick agrin to Matrigel™ requires
the first 130 amino acids at the NH2 terminus of full-length
agrin (Denzer et al., 1995). We now find that laminin-1,
one component of Matrigel™, serves as a binding partner
for chick agrin. The binding of recombinant cAgrin7 (Fig.
1 a) to laminin-1 is of high affinity (EC50 of z5 nM; Fig. 4)
and is mainly carried by the NH2-terminal end of agrin as
an excess of the NH2-terminal fragment, cN257Fc, com-
petes the binding of full-length agrin by more than 90%.
Although cN257Fc includes the first follistatin-like do-
main, this domain is not necessary for the binding to lami-
nin-1 (Denzer, A.J., and M.A. Ruegg, unpublished obser-
vation). The stretch preceding the follistatin-like domain is
the most highly conserved region of agrin (Fig. 6). This
high homology and the fact that this region in chick agrin
mediates binding to all laminin isoforms so far tested (i.e.,
laminin-1, -2, and -4) strongly suggest it being important
for the integration of agrin into the scaffold of ECM mole-
cules formed by the self-assembled laminins and collagen
type IV. Since no homology to any so far defined modules
Figure 9. The NH2-terminal, laminin-binding domain of agrin
causes AChR clusters to be small. (a) Fluorescence micrographs of
cultured chick myotubes labeled with rhodamine–a-bungarotoxin.
Myotubes were grown for 12 h in the presence of conditioned
medium of transiently transfected COS cells containing either
100 pM cAgrin7A4B8 or cDN15AgrinA4B8. AChR clusters induced
by cAgrin7A4B8 are considerably smaller than those induced by
cDN15AgrinA4B8. In the presence of cN257Fc, the size of
cAgrin7A4B8-induced AChR clusters increases. (b) Quantification
of the effect on the size of the AChR aggregates. The presence of
500 nM cN257Fc (1 cN257Fc) increases the size of the AChR
clusters induced by cAgrin7A4B8 twofold and makes them indistin-
guishable from AChR clusters induced by cDN15AgrinA4B8. In
contrast, addition of 500 nM cN257Fc does not alter the size of
cDN15AgrinA4B8-induced AChR aggregates. The result (mean 6
SEM) of one representative experiment is shown where the size
of AChR clusters in 20 myotube segments was determined. Bar,
50 mm.Denzer et al. Agrin Binds to Laminins 681
was found using BLAST or FASTA algorithms (Altschul
et al., 1990; Pearson and Lipman, 1988), we propose to call
this novel module NtA domain (for NH2-terminal domain
in agrin; see also Fig. 1 a).
The binding of the NtA domain of agrin to laminin-1 is
confined to a particular region in the upper part of the tri-
ple coiled-coil domain of laminin-1, as shown by the bind-
ing of cN257Fc to proteolytic fragments of laminin-1 and
visualization of this interaction by electron microscopy af-
ter rotary shadowing (Denzer, A.J., T. Schulthess, C.
Fauser, B. Schumacher, J. Engel, and M.A. Ruegg, manu-
script in preparation). These results show that the binding
of agrin to laminin-1 is mediated by specific domains in
both molecules and they support the result of this study
(Fig. 4) that the agrin–laminin interaction is of high affinity.
Binding of Agrin to Laminin and Its Role
in AChR Aggregation
Induction and maintenance of postsynaptic differentiation
at nerve–muscle contacts in vivo is triggered by neural
agrin in a restricted area of muscle fibers (McMahan,
1990). The simplest explanation for this local action of
neural agrin is that it becomes trapped in the extracellular
matrix near its release site, the tip of the motor neuron’s
axon. Although we cannot exclude that other molecules
are also involved in this process, we propose that the local
immobilization of neural agrin is mainly mediated by its
binding to laminin isoforms expressed by muscle fibers.
Consistent with this view, the fragment cN257Fc binds to
purified laminin-2 and -4 (Fig. 7), the two main laminin
isoforms expressed in developing muscle fibers (Chiu and
Sanes, 1984; Sanes et al., 1990). In addition, agrin-like pro-
tein copurifies with laminin isoforms (Fig. 7 a), and
cN257Fc colocalizes with laminin and AChR clusters on
cultured myotubes (Fig. 8). Similarly, laminin-like immu-
noreactivity colocalizes with agrin-like protein in chick
embryo hindlimb muscle in vivo and in vitro, and both
proteins are enriched in AChR clusters (Godfrey et al.,
1988b; Nitkin and Rothschild, 1990). The binding of neural
agrin to laminin would also explain earlier observations
that motor neuron–derived agrin associates with the earli-
est AChR clusters in frog nerve–muscle cocultures (Cohen
and Godfrey, 1992) and that it is deposited onto culture
substrates containing laminin (Cohen et al., 1994).
We have shown that the size of agrin-induced AChR ag-
gregates is affected by the NtA domain of agrin (Denzer et
al., 1995; Fig. 9). On cultured chick myotubes, the size of
cDN15AgrinA4B8-induced AChR clusters is indistinguish-
able from the size of the clusters induced by c21B8, the
minimal fragment required for AChR aggregation that
does not bind to a-dystroglycan (see Figs. 8 and 9; Gese-
mann et al., 1996). Hence, unlike the binding of agrin to
a-dystroglycan, the NtA domain has a clear effect on the
size of the AChR clusters. One explanation for this phe-
nomenon may be that agrin becomes immobilized on the
muscle cell surface by its binding to laminin and thereby
prevents small AChR clusters from fusing (see also Dis-
cussion in Denzer et al., 1995).
We also think that the binding to laminin is the molecu-
lar basis that, after degeneration of the nerve terminals
and the muscle fibers, AChR-aggregating activity and agrin-
like immunoreactivity is maintained at former synaptic
sites for several weeks (Burden et al., 1979; Reist et al.,
1987). At least in vitro, the tight association of agrin with
muscle cell basal lamina requires the NtA domain; cul-
tured chick myotubes that are incubated for only 30 min
with AChR-aggregating full-length agrin (cAgrin7A4B8),
subsequently washed and further incubated for 15 h in
agrin-free culture medium, show agrin-induced AChR ag-
gregates. In contrast to this, no AChR clusters are induced
with the same paradigm using cDN15AgrinA4B8 or any
other active, COOH-terminal agrin fragment (Denzer, A.J.,
and M.A. Ruegg, unpublished data). Our observation that
cDN15AgrinA4B8 is not capable of inducing AChR clusters
by short-term incubation is similar to results of Wallace
(1988), who showed that maintenance of AChR clusters in
vitro needs the continuous presence of agrin. Since his
agrin preparation mainly contained proteolytic fragments
of the COOH-terminal half of agrin (Nitkin et al., 1987),
these fragments also lack the NtA domain.
Binding of Agrin to Laminin Isoforms and 
Neuromuscular Junction Development In Vivo
Upon formation of primary muscle fibers, b1-containing
laminin isoforms are expressed throughout the muscle cell
basal lamina (Chiu and Sanes, 1984; Schuler and Sorokin,
1995). At later stages of synaptogenesis, the b2 chain of
laminin (s-laminin) accumulates in synaptic basal lamina,
and the b1 chain is displaced from this region and contin-
ues to be expressed extrasynaptically (Chiu and Sanes,
1984; Hunter et al., 1989; Sanes et al., 1990). In contrast to
the b chains, the a2 and g1 chains are found throughout
the muscle fiber basal lamina (Sanes et al., 1990). These
results strongly suggest that laminin-2 (a2, b1, g1) and
laminin-4 (a2, b2, g1) are the laminin isoforms in the ex-
trasynaptic and synaptic basal laminae, respectively. We
find that, at one particular concentration, laminin-4 binds
more strongly to agrin than laminin-2 (Fig. 7). Hence,
agrin may preferentially bind to laminin-4, and this may be
the basis of the tight association of neural agrin with syn-
aptic basal lamina throughout adulthood.
Similarly, the phenotype of mice that are deficient of the
b2 chain of laminin may, at least partially, be based on al-
terations of agrin. In these mice, NMJs are formed on
schedule, but maturation of pre- and postsynaptic special-
izations is impaired, and terminal Schwann cells penetrate
partially the synaptic cleft (Noakes et al., 1995). Although
the loss of the b2 chain is compensated by continued ex-
pression of the b1 chain at the NMJ (Martin et al., 1996),
this may not be sufficient to tether agrin to the NMJ. Since
agrin has been shown to influence the formation of pre-
synaptic specializations (Campagna et al., 1995; Gautam
et al., 1996), alterations in the binding of agrin to the NMJ
may also explain the abnormalities in presynaptic special-
ization in the b2-deficient mice.
For the current studies, we used agrin isoforms that in-
clude a 7–amino acid insert at the NH2-terminal splice site.
Motor neurons in the developing chick spinal cord contain
agrin transcripts encoding this agrin variant, whereas the
majority of agrin mRNA in nonneuronal cells codes for
agrin without the insert (Denzer et al., 1995; Tsen et al.,
1995b). Interestingly, the cDNA clones encoding mouseThe Journal of Cell Biology, Volume 137, 1997 682
and human agrin, which are derived from nonneuronal tis-
sue, all encode the splice variant lacking the insert (Fig. 6).
Preliminary results show that both splice variants bind to
laminin-1 (Denzer, A.J., and M.A. Ruegg, unpublished
observation). Since there appears to be a difference in the
binding of the two splice variants to Matrigel™ (Denzer et
al., 1995), it will be interesting to see whether splicing at
this site influences binding of agrin to different laminin
isoforms.
Little is known about the function of agrin isoforms
without AChR-aggregating activity. Since these inactive iso-
forms bind more strongly to a-dystroglycan than AChR-
aggregating isoforms and since they also bind to laminin,
the inactive isoforms might have a structural role to link
the basement membrane with the underlying cytoskeleton
via the dystrophin–glycoprotein complex (for reviews see
Campbell, 1995; Worton, 1995). We have now generated
the tools that will enable studies on the physiological sig-
nificance of the binding of agrin to laminin isoforms and to
the different binding proteins expressed on the muscle cell
membrane, like a-dystroglycan.
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